e-Drug3D 289 |
ETHOSUXIMIDE
|
cas 77-67-8 |
CLASS NERVOUS SYSTEM |
ROUTE (list) ORAL |
PK parameters Tmax 5 HOUR |
Target TARGET VOLTAGE-DEPENDENT CHANNEL |
DrugCentral Voltage-dependent T-type calcium channel subunit alpha-1G UNIPROT O43497 CACNA1G |
Download SDF file | 3-ethyl-3-methylpyrrolidine-2,5-dione Formula: Calculated chemical properties: MW 141.17 NB_atoms 10 XLogP 0.45 PSA 47.114 NB_HD 1 NB_HA 3 fsp3 0.71 Lipinski(0=no;1=yes) 1 |
FDA NDA 012380 (label) INN (ETHOSUXIMIDE) ZARONTIN (PARKE DAVIS) APPROVAL= AP YEAR= 1960 NDA 080258 (label) INN (ETHOSUXIMIDE) ZARONTIN (PARKE-DAVIS) APPROVAL= AP YEAR= 1974 NDA 081306 (pdf not found) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (TEVA PHARMS) APPROVAL= AP YEAR= 1993 DISCONTINUED NDA 040253 (label) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (PHARM ASSOC) APPROVAL= AP YEAR= 2000 NDA 040430 (pdf not found) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (BIONPHARMA) APPROVAL= AP YEAR= 2002 NDA 040506 (pdf not found) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (CHARTWELL RX) APPROVAL= AP YEAR= 2003 NDA 040686 (pdf not found) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (EPIC PHARMA LLC) APPROVAL= AP YEAR= 2008 NDA 200892 (pdf not found) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (HERITAGE PHARMS INC) APPROVAL= AP YEAR= 2012 NDA 211928 (pdf not found) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (ONESOURCE SPECIALTY) APPROVAL= AP YEAR= 2019 NDA 210654 (pdf not found) INN (ETHOSUXIMIDE) ETHOSUXIMIDE (PURACAP PHARM LLC) APPROVAL= AP YEAR= 2020 |
Other links: |